Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Adalimumab was first approved in the U.S. for the treatment of aforementioned medical conditions. Currently, this is marketed in more than 60 countries. However, owing to the biologic nature of the drug, it results in high cost and low accessibility in emerging economies such as LATAM and Asia Pacific. On the other hand, with the probable entry of the adalimumab biosimilars post the patent expiry the low costs up to less than 25% to 35% of the originator drugs will boost the uptake and prescription of adalimumab for the treatment of above mentioned medical conditions.
This report elaborates on the current development of the LATAM Adalimumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novartis AG
Boehringer Ingelheim GmbH
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Oral Type
Injection Type
Application:
Rheumatoid Arthritis
Psoriasis
Crohn’s Disease
Ulcerative Colitis
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 LATAM Adalimumab Industry Overview
-
1.1.1 LATAM Adalimumab Market Scope and Market Segments
-
1.1.2 LATAM Adalimumab Industry Characteristics
-
1.1.3 Global and China LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China LATAM Adalimumab Production Value and Growth Rate (2017-2028)
-
1.2 Global LATAM Adalimumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Oral Type
-
1.2.2 Injection Type
-
1.3 Global LATAM Adalimumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Rheumatoid Arthritis
-
1.3.2 Psoriasis
-
1.3.3 Crohn’s Disease
-
1.3.4 Ulcerative Colitis
-
1.3.5 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global LATAM Adalimumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global LATAM Adalimumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China LATAM Adalimumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China LATAM Adalimumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global LATAM Adalimumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 LATAM Adalimumab Industry Porter's Five Forces Model Analysis
-
2.2.3 LATAM Adalimumab Industry PEST Analysis
-
2.3 LATAM Adalimumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 LATAM Adalimumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on LATAM Adalimumab Industry
Chapter 3 Global and China LATAM Adalimumab Market, by Manufacturer
-
3.1 Global and China LATAM Adalimumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China LATAM Adalimumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China LATAM Adalimumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China LATAM Adalimumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China LATAM Adalimumab Market Top 3 Players
Chapter 4 Global and China LATAM Adalimumab Market, by Type (2017-2028)
-
4.1 LATAM Adalimumab Market Trend, by Type
-
4.2 Global LATAM Adalimumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global LATAM Adalimumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global LATAM Adalimumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global LATAM Adalimumab Price Trend, by Type (2017-2028)
-
4.3 China LATAM Adalimumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China LATAM Adalimumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China LATAM Adalimumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China LATAM Adalimumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China LATAM Adalimumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global LATAM Adalimumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global LATAM Adalimumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global LATAM Adalimumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China LATAM Adalimumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China LATAM Adalimumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China LATAM Adalimumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global LATAM Adalimumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America LATAM Adalimumab Market Analysis
-
7.1 North America LATAM Adalimumab Market, by Type
-
7.2 North America LATAM Adalimumab Market, by Application
-
7.3 North America LATAM Adalimumab Market Analysis and Forecast, by Country
-
7.3.1 United States LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe LATAM Adalimumab Market Analysis
-
8.1 Europe LATAM Adalimumab Market, by Type
-
8.2 Europe LATAM Adalimumab Market, by Application
-
8.3 Europe LATAM Adalimumab Market Analysis and Forecast, by Country
-
8.3.1 Germany LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC LATAM Adalimumab Market Analysis
-
9.1 APAC LATAM Adalimumab Market, by Type
-
9.2 APAC LATAM Adalimumab Market, by Application
-
9.3 APAC LATAM Adalimumab Market Analysis and Forecast, by Country
-
9.3.1 China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa LATAM Adalimumab Market Analysis
-
10.1 Latin America, Middle East and Africa LATAM Adalimumab Market, by Type
-
10.2 Latin America, Middle East and Africa LATAM Adalimumab Market, by Application
-
10.3 Latin America, Middle East and Africa LATAM Adalimumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina LATAM Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China LATAM Adalimumab Company Profiles
-
11.1 Novartis AG
-
11.1.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novartis AG LATAM Adalimumab Product Profiles, Application and Specification
-
11.1.3 Novartis AG LATAM Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Boehringer Ingelheim GmbH
-
11.2.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Boehringer Ingelheim GmbH LATAM Adalimumab Product Profiles, Application and Specification
-
11.2.3 Boehringer Ingelheim GmbH LATAM Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 LATAM Adalimumab Industry Investment Prospect and Risk Assessment
-
12.1 LATAM Adalimumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 LATAM Adalimumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure China LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global LATAM Adalimumab Production Value and Growth Rate (2017-2028)
-
Figure China LATAM Adalimumab Production Value and Growth Rate (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Oral Type (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Injection Type (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Rheumatoid Arthritis (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Psoriasis (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Crohn’s Disease (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Ulcerative Colitis (2017-2028)
-
Figure Global LATAM Adalimumab Market Size and Growth Rate of Others (2017-2028)
-
Figure North America LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa LATAM Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global LATAM Adalimumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China LATAM Adalimumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China LATAM Adalimumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China LATAM Adalimumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China LATAM Adalimumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China LATAM Adalimumab Market Share, by Manufacturer in 2021
-
Figure Global and China LATAM Adalimumab Market Share, by Manufacturer in 2022
-
Table Global LATAM Adalimumab Sales Volume, by Type (2017-2028)
-
Table Global LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure Global LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table Global LATAM Adalimumab Sales Value, by Type (2017-2028)
-
Table Global LATAM Adalimumab Sales Value Share, by Type (2017-2028)
-
Figure Global LATAM Adalimumab Price Trend, by Type (2017-2028)
-
Table China LATAM Adalimumab Sales Volume, by Type (2017-2028)
-
Table China LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure China LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table China LATAM Adalimumab Sales Value, by Type (2017-2028)
-
Table China LATAM Adalimumab Sales Value Share, by Type (2017-2028)
-
Figure China LATAM Adalimumab Price Trend, by Type (2017-2028)
-
Table Global LATAM Adalimumab Sales Volume, by Application (2017-2028)
-
Table Global LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Global LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Table Global LATAM Adalimumab Sales Value, by Application (2017-2028)
-
Table Global LATAM Adalimumab Sales Value Share, by Application (2017-2028)
-
Figure Global LATAM Adalimumab Sales Value Share, by Application (2017-2028)
-
Table China LATAM Adalimumab Sales Volume, by Application (2017-2028)
-
Table China LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure China LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Table China LATAM Adalimumab Sales Value, by Application (2017-2028)
-
Table China LATAM Adalimumab Sales Value Share, by Application (2017-2028)
-
Figure China LATAM Adalimumab Sales Value Share, by Application (2017-2028)
-
Figure China LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa LATAM Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Table North America LATAM Adalimumab Sales Volume, by Type (2017-2028)
-
Table North America LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure North America LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table North America LATAM Adalimumab Sales Volume, by Application (2017-2028)
-
Table North America LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure North America LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure United States LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table Europe LATAM Adalimumab Sales Volume, by Type (2017-2028)
-
Table Europe LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table Europe LATAM Adalimumab Sales Volume, by Application (2017-2028)
-
Table Europe LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure UK LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure France LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure France LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table APAC LATAM Adalimumab Sales Volume, by Type (2017-2028)
-
Table APAC LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table APAC LATAM Adalimumab Sales Volume, by Application (2017-2028)
-
Table APAC LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure China LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure China LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure India LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure India LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa LATAM Adalimumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa LATAM Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa LATAM Adalimumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa LATAM Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina LATAM Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina LATAM Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG LATAM Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification
-
Table Boehringer Ingelheim GmbH LATAM Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
